JSR Corporation announced that Medical & Biological Laboratories (MBL) and Crown Bioscience, JSR Life Sciences companies, have formed a joint venture to further extend their preclinical services to Japanese customers. The new company named “Crown Bioscience & MBL”, provides preclinical and translational services to biopharmaceutical customers in Japan. MBL is currently a distributor for Crown Bioscience and the establishment of the joint venture marks a significant milestone in the long-standing relationship between the two founding companies.

The company, established in April 2022, is expected to start service operation from September 2022. For details, please refer to the announcements from Crown Bioscience.
https://blog.crownbio.com/press/crown-bioscience-and-mbl-enter-joint-venture

About Crown Bioscience & MBL

Location: Tokyo, Japan

Representative: Hiroki Ito

Purpose of Enterprise: Preclinical and translational services to biopharmaceutical customers

Date of Establishment: April 2022